511509 VIVOBIOT

Vivo Bio Tech Share Price

 

 

Start SIP in VIVOBIOT

Start SIP

Performance

  • Low
  • ₹31
  • High
  • ₹32
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹57
  • Open Price₹32
  • Previous Close₹32
  • Volume3,008

Investment Returns

  • Over 1 Month + 3.21%
  • Over 3 Month -15.37%
  • Over 6 Month -14.86%
  • Over 1 Year -15.16%

Smart Investing Starts Here Start SIP with Vivo Bio Tech for Steady Growth!

Invest Now

Vivo Bio Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.6
  • PEG Ratio
  • -0.3
  • Market Cap Cr
  • 52
  • P/B Ratio
  • 0.6
  • Average True Range
  • 1.93
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.27
  • RSI
  • 53.54
  • MFI
  • 72.17

Vivo Bio Tech Financials

Vivo Bio Tech Technicals

EMA & SMA

Current Price
₹31.98
+ 0.39 (1.23%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹30.77
  • 50 Day
  • ₹31.77
  • 100 Day
  • ₹33.45
  • 200 Day
  • ₹35.26

Resistance and Support

31.58 Pivot Speed
  • R3 32.69
  • R2 32.32
  • R1 31.95
  • S1 31.21
  • S2 30.84
  • S3 30.47

Vivo Bio Tech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-12 Quarterly Results
2025-05-19 Audited Results
2025-01-09 Quarterly Results
2024-11-21 Employees Stock Option Plan

Vivo Bio Tech F&O

Vivo Bio Tech Shareholding Pattern

35.16%
32.3%
32.54%

Vivo Bio Tech FAQs

Vivo Bio Tech share price is ₹31 As on 01 January, 2026 | 13:18

The Market Cap of Vivo Bio Tech is ₹51.6 Cr As on 01 January, 2026 | 13:18

The P/E ratio of Vivo Bio Tech is 12.6 As on 01 January, 2026 | 13:18

The PB ratio of Vivo Bio Tech is 0.6 As on 01 January, 2026 | 13:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23